Arthritis Australia welcomes funding for kids with arthritis
Discover more...
-
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed funding for Arthritis Australia and...
-
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations...
-
Arthritis Australia welcomes cheaper arthritis medicines
More medicines now eligible for 60 day dispensing from March 1 2024 [Sydney, Australia] Arthritis Australia has welcomed access to cheaper medicines commonly used to...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: